Updating results

193 results

Sort: Relevance | Date

Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)

Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Medtech innovation briefing Published December 2017

HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (MIB128)

Advice on the use of HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published November 2017

RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)

Advice on the use of RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (IBD) to aid local decision-making

Medtech innovation briefing Published June 2017

Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)

Advice on the use of point-of-care (POC) creatinine tests for measuring kidney function before contrast-enhanced imaging to aid local decision-making

Medtech innovation briefing Published January 2018

EpiFix for chronic wounds (MIB139)

Advice on the use of EpiFix (an allograft comprising dehydrated human amnion/chorion membrane tissue/dHACM) for chronic wounds to aid local decision-making

Medtech innovation briefing Published January 2018

Biopatch for venous or arterial catheter sites (MIB117)

Advice on the use of Biopatch hydrophilic foam dressing with chlorhexidine gluconate (CHG) for venous or arterial catheter sites to aid local decision-making

Medtech innovation briefing Published August 2017

Caris Molecular Intelligence for guiding cancer treatment (MIB120)

Advice on the use of Caris Molecular Intelligence (CMI; solid tumour biomarker analysis service) for guiding cancer treatment to aid local decision-making

Medtech innovation briefing Published September 2017

myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

Advice on the use of myAIRVO2 (warms and humidifies respiratory gases) for treating chronic obstructive pulmonary disease (COPD) to aid local decision-making

Medtech innovation briefing Published October 2018

NephroCheck test to help assess the risk of acute kidney injury in critically ill patients (MIB156)

Advice on the use of NephroCheck test (Ortho Clinical Diagnostics) to help assess acute kidney injury risk in critically ill patients to aid local decision

Medtech innovation briefing Published August 2018

eazyplex SuperBug kits for detecting carbapenemase-producing organisms (MIB94)

Advice on the use of eazyplex SuperBug kits for detecting carbapenemase-producing organisms (bacteria) to aid local decision-making

Medtech innovation briefing Published February 2017

Smartinhaler for asthma (MIB90)

Advice on the use of Smartinhaler for monitoring the activation of asthma inhalers to aid local decision-making

Medtech innovation briefing Published January 2017

Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)

Advice on the use of the Alere Afinion CRP for C-reactive protein testing in primary care to aid local decision-making

Medtech innovation briefing Published September 2016

Otovent nasal balloon for otitis media with effusion (MIB59)

Advice on the use of the Otovent nasal balloon for relieving the symptoms of otitis effusion (glue ear) to aid local decision-making

Medtech innovation briefing Published March 2016

Lutonix drug-coated balloon for peripheral arterial disease (MIB72)

Advice on the use of Lutonix drug-coated balloon (DCB; Lutonix 035) for treating peripheral arterial disease (PAD) to aid local decision-making

Medtech innovation briefing Published July 2016

QuikRead go for C-reactive protein testing in primary care (MIB78)

Advice on the use of QuickRead go for C-reactive protein (CRP) testing in primary care to aid local decision-making

Medtech innovation briefing Published September 2016

Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)

Advice on the use of Woundchek Protease Status for assessing elevated protease status in chronic wounds to aid local decision-making

Medtech innovation briefing Published October 2016

Needle-free arterial non-injectable connector (MIB85)

Advice on the use of needle-free arterial non-injectable connector through which blood samples can be collected to aid local decision-making

Medtech innovation briefing Published October 2016

FLEXISEQ for osteoarthritis (MIB80)

Advice on the use of FLEXISEQ for treating the symptoms of osteoarthritis to aid local decision-making

Medtech innovation briefing Published September 2016

The V.A.C. Veraflo Therapy system for infected wounds (MIB189)

Advice on the use of the V.A.C. Veraflo Therapy system for infected wounds to aid local decision making

Medtech innovation briefing Published September 2019

FreeStyle Libre for glucose monitoring (MIB110)

Advice on the use of FreeStyle Libre for monitoring glucose levels in diabetes to aid local decision-making

Medtech innovation briefing Published July 2017 Last updated September 2017

InterDry for intertrigo (MIB192)

Advice on the use of InterDry for intertrigo (inflammatory skin rash) to aid local decision making

Medtech innovation briefing Published September 2019

UroShield for preventing catheter-associated urinary tract infections (MIB191)

Advice on the use of UroShield for preventing catheter-associated urinary tract infections (CAUTI) to aid local decision making

Medtech innovation briefing Published September 2019

SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea (MIB190)

Advice on the use of SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea to aid local decision making

Medtech innovation briefing Published September 2019

OxyMask for delivering oxygen therapy (MIB160)

Advice on the use of OxyMask for delivering oxygen therapy to aid local decision-making

Medtech innovation briefing Published September 2018

Alpha-Stim AID for anxiety (MIB193)

Advice on the use of Alpha-Stim AID for anxiety to aid local decision making

Medtech innovation briefing Published September 2019

Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (MIB137)

Advice on the use of plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published January 2018

Smart One for measuring lung function (MIB96)

Advice on the use of Smart One for measuring lung function to aid local decision-making

Medtech innovation briefing Published February 2017

Health app: GDm-Health for people with gestational diabetes (MIB131)

Advice on the GDm-Health app to remotely monitor blood glucose in people with gestational diabetes (diabetes in pregnancy) to aid local decision-making

Medtech innovation briefing Published November 2017

Fungitell for antifungal treatment stratification (MIB118)

Advice on the use of the Fungitell assay for detecting fungal infections (pathogens, fungus, fungi) in guiding antifungal treatment to aid local decision-making

Medtech innovation briefing Published August 2017

The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodies (MIB24)

Advice on the use of the OraQuick HCV point-of-care test for rapid detection of hepatitis C virus antibodies to aid local decision-making

Medtech innovation briefing Published March 2015

S-Cath System for suprapubic catheterisation (MIB68)

Advice on the use of the S-Cath System for suprapubic catheterisation to aid local decision-making

Medtech innovation briefing Published June 2016

Curos disinfecting cap for needleless connectors (MIB143)

This advice has been updated and replaced by NICE medical technologies guidance 44.

Medtech innovation briefing Published April 2018

Ultroid 2.0 for internal haemorrhoids (MIB75)

This medtech innovation briefing is temporarily unavailable, please contact mibs@nice.org.uk for further information.

Medtech innovation briefing Published July 2016

The ZedScan as an adjunct to colposcopy in women with suspected cervical intra‑epithelial neoplasia (MIB20)

This advice has been updated and replaced by NICE diagnostics guidance 32.

Medtech innovation briefing Published February 2015

The BCM – Body Composition Monitor for managing fluid in people having dialysis (MIB41)

This guidance has been updated and replaced by NICE diagnostics guidance 29.

Medtech innovation briefing Published October 2015

The Prosigna gene expression profiling assay for assessing long‑term risk of breast cancer recurrence (MIB27)

This guidance has been updated and replaced by NICE diagnostics guidance 34.

Medtech innovation briefing Published March 2015

EndoPredict gene expression profiling assay for assessing risk of breast cancer recurrence (MIB44)

This guidance has been updated and replaced by NICE diagnostics guidance 34.

Medtech innovation briefing Published November 2015

PICO negative pressure wound therapy for closed surgical incision wounds (MIB149)

This advice has been updated and replaced by NICE medical technologies guidance 43.

Medtech innovation briefing Published June 2018

Mepilex Border dressings for preventing pressure ulcers (MIB124)

This advice has been updated and replaced by NICE medical technologies guidance 40.

Medtech innovation briefing Published October 2017

Eyemax mono for age-related macular degeneration (MIB154)

We’ve temporarily withdrawn this medtech innovation briefing to correct factual errors in the text.

Medtech innovation briefing Published August 2018

Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

NICE withdrew this MIB in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

Medtech innovation briefing Published October 2016

UrgoStart for chronic wounds (MIB82)

This advice has been updated and replaced by NICE medical technologies guidance 42.

Medtech innovation briefing Published October 2016

Promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126)

This advice has been replaced by NICE diagnostics guidance 36.

Medtech innovation briefing Published October 2017